Wearable Injectors111

Issue No #111 Sep 2020 September 18th, 2020

Inside the magazine

WEARABLE INJECTORS: LATEST DEVICES & RECENT TRENDS

WEARABLE INJECTORS: LATEST DEVICES & RECENT TRENDS

Wearable injection device expert Tom Oakley discusses recent trends in the space. He also takes a look at wearable injection devices currently on the market and considers the future of wearable injectors.

EASING PATIENT EXPERIENCE WITH INNOVATIVE LARGE-VOLUME WEARABLES

Victoria Morgan

West Pharmaceutical Services

EASING PATIENT EXPERIENCE WITH INNOVATIVE LARGE-VOLUME WEARABLES

Victoria Morgan discusses the growing sector of wearable injectors, with a specific focus on West’s own SmartDose^® injector and the value of fill-finish services.

STABILITY OF A WEARABLE INJECTOR POWERED BY OSMOSIS

STABILITY OF A WEARABLE INJECTOR POWERED BY OSMOSIS

Jesper Roested and Tomas Gundberg present engineering test data on Subcuject’s wearable bolus injector, based on an osmotic drive system, demonstrating that the device presents a solution to the need for an inexpensive, mass-producible wearable injector.

ANDREI YOSEF, CEO, SORREL MEDICAL

Dr Andrei Yosef

ANDREI YOSEF, CEO, SORREL MEDICAL

In this exclusive interview, Andrei Yosef discusses Sorrel’s differentiated electro-mechanical, connected wearable injection platform, and two exciting recent milestones for the company, the opening of a state-of-the-art manufacturing facility and the signing of a significant partnership with a large pharma company.

MEETING THE NEED FOR HIGH-VOLUME DRUG DELIVERY WITH ON-BODY BOLUS INJECTORS

E3D – Elcam Drug Delivery Devices

MEETING THE NEED FOR HIGH-VOLUME DRUG DELIVERY WITH ON-BODY BOLUS INJECTORS

Tsachi Shaked shows how on-body injectors present a safe and viable solution for high-volume drug delivery.

EMERGING TRENDS IN WEARABLE DRUG DELIVERY

Phillips-Medisize

EMERGING TRENDS IN WEARABLE DRUG DELIVERY

Tony Bedford discusses the current state of the fledgling on-body injector market, including the difficulties of competing with autoinjectors in the <5 mL space, the potential on-body injectors have in oncology and Phillips-Medisize’s own developments in the on-body injector field.

SIMPLIFYING LARGE-VOLUME PATCH INJECTION FOR PHARMA AND PATIENTS

SIMPLIFYING LARGE-VOLUME PATCH INJECTION FOR PHARMA AND PATIENTS

Reto Jost provides an update on the YpsoDose platform and its importance as the driver for the business unit’s new patch injector franchise.

THE NEW PATIENT-CENTRICITY

Enable Injections

THE NEW PATIENT-CENTRICITY

Jennifer Estep discusses the new pressures put on the healthcare system by the covid-19 pandemic, and how patients and healthcare providers alike are turning to patient-centric solutions to minimise risks and ease burdens.

TECHNOLOGY SHOWCASE: CCBio’s QuickDose

TECHNOLOGY SHOWCASE: CCBio’s QuickDose

CCBio is introducing a new era of wearable on-body medical devices. QuickDose, recently successfully developed with both patients and pharmaceutical industry partners in mind, contains all the necessary elements for an excellent on-body device, comprising three major technical achievements.